Achieved Trade Building and Licensing Govt to Power NTS’s Trade Building and Partnering Actions
ATLANTA, July 31, 2023 /PRNewswire/ — NeuroTrauma Sciences, LLC (NTS), a non-public biopharmaceutical corporate growing neuroprotective therapeutics for treating central anxious gadget (CNS) accidents, together with stroke and disturbing mind harm, these days introduced the appointment of Kevin Pong, PhD, MBA as Leader Trade Officer. On this place, Dr. Pong is liable for the strategic management of the corporate’s international enterprise construction, licensing, and alliance control actions.
“We’re thrilled to welcome Kevin to our government management group,” mentioned Carl Lengthy, Leader Govt Officer. “His deep enjoy in enterprise construction and partnering technique and talent to foster robust enterprise relationships, blended with a background in neuroscience, can be treasured as we development our lead program NTS-104 in stroke in the course of the sanatorium and advance our essential paintings in disturbing mind harm.”
Dr. Pong brings to NTS greater than two decades of business enjoy with a a hit observe report of industrial construction and licensing transactions in biotech and pharmaceutical corporations. Maximum not too long ago, he served as Leader Trade Officer of Anima Biotech, the place he drove more than one transformative transactions and helped evolve the corporate’s partnering technique. Previous to Anima, he served as vice chairman of industrial construction, licensing, and alliance control at Summit Therapeutics and led the identity, analysis, and negotiation of CNS enterprise construction alternatives at Sunovion Prescribed drugs. He spent a number of years at Endo Prescribed drugs in enterprise construction roles of accelerating accountability and held management roles in discovery neuroscience analysis at Wyeth. Dr. Pong holds a B.S. in Organic Sciences, a Ph.D. in Neuroscience from the College of Southern California, and an MBA from Rutgers College.
“I’m focused on the prospective I see in NTS and the chance to be part of the group advancing compounds within the seriously underserved spaces of stroke and disturbing mind harm,” mentioned Dr. Pong. “I’m thrilled to be running within the neuroscience box once more and sit up for leveraging my experience and community.”
About NeuroTrauma Sciences
NeuroTrauma Sciences is a biopharmaceutical corporate advancing its challenge to expand neuroprotective remedies for treating CNS accidents, together with ischemic stroke and disturbing mind harm (TBI). Bought mind accidents stay spaces of top unmet want with restricted healing choices to relieve the cognitive, practical, and neurobehavioral results for thousands and thousands of sufferers international. By way of leveraging insights into the biology of bought mind harm, NTS is advancing a pipeline of applicants focused on ischemic stroke and TBI. For more information, please consult with www.neurotraumasciences.com.
Contacts:
NeuroTrauma Sciences
David Lawrence
Leader Monetary Officer
M: 845-548-6311
d.lawrence@neurotraumasciences.com
SMP Communications
Susan Pietropaolo
M: 201-923-2049
susan@smpcommunications.com
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/neurotrauma-sciences-appoints-kevin-pong-phd-mba-as-chief-business-officer-301887676.html
SOURCE NeuroTrauma Sciences, LLC
